Stefano Pessina - 19 Oct 2021 Form 4 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Role
Executive Chairman of Board, Director, 10%+ Owner
Signature
Benjamin S.J. Burman, attorney-in-fact
Issuer symbol
WBA
Transactions as of
19 Oct 2021
Net transactions value
-$1,597,581
Form type
4
Filing time
21 Oct 2021, 18:37:06 UTC
Next filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WBA Common Stock, par value $0.01 per share Award $0 +164,681 +46% $0.000000 523,714 19 Oct 2021 Direct F1, F2
transaction WBA Common Stock, par value $0.01 per share Tax liability $1,597,581 -33,276 -6.4% $48.01 490,438 19 Oct 2021 Direct F2, F3
holding WBA Common Stock, par value $0.01 per share 144,788,821 19 Oct 2021 By ASP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding WBA Employee Stock Option (right to buy) 263,273 19 Oct 2021 Common Stock 263,273 $77.08 Direct F5
holding WBA Employee Stock Option (right to buy) 410,798 19 Oct 2021 Common Stock 410,798 $82.46 Direct F6
holding WBA Employee Stock Option (right to buy) 504,710 19 Oct 2021 Common Stock 504,710 $67.01 Direct F7
holding WBA Employee Stock Option (right to buy) 395,061 19 Oct 2021 Common Stock 395,061 $79.90 Direct F8
holding WBA Employee Stock Option (right to buy) 420,168 19 Oct 2021 Common Stock 420,168 $57.38 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued upon settlement of performance share award (not a derivative security within the meaning of Rule 16a-1(c)) granted on November 1, 2018 under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan").
F2 Includes 4,206 shares underlying restricted stock units issued in lieu of dividends (through October 21, 2021) on outstanding restricted stock units.
F3 Disposition relating to the satisfaction of tax withholding obligations upon the settlement of performance share award granted in accordance with Rule 16b-3.
F4 Shares of Common Stock are held of record by a corporation, Alliance Sante Participations S.A. ("ASP") which is 100% owned by another corporation, NewCIP II S.a r.l., which is 100% controlled by the Reporting Person.
F5 The option vested on February 12, 2019, subject to forfeiture in certain circumstances in accordance with the terms and conditions of the Plan (together with the related agreement thereunder).
F6 The option vested on November 1, 2019, subject to forfeiture in certain circumstances in accordance with the terms and conditions of the Plan (together with the related agreement thereunder).
F7 The option vested with respect to 168,068 shares on November 1, 2018, with respect to a further 168,068 shares on November 1, 2019, and with respect to 168,574 shares on November 1, 2020, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan (together with the related agreement thereunder).
F8 The option vested with respect to 131,555 shares on November 1, 2019 and with respect to a further 131,555 shares on November 1, 2020 and vests with respect to 131,951 shares on November 1, 2021, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan (together with the related agreement thereunder).
F9 The option vested with respect to 139,916 shares on November 1, 2020 and vests with respect to a further 139,916 shares on November 1, 2021 and with respect to 140,336 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan (together with the related agreement thereunder).